NorthCrest Asset Manangement’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,320
Closed -$213K 500
2023
Q2
$213K Buy
+4,320
New +$199K 0.01% 483
2022
Q2
Sell
-3,200
Closed -$210K 433
2022
Q1
$210K Buy
+3,200
New +$207K 0.01% 392

Other funds holding ATRC

NorthCrest Asset Manangement's ATRC Position: Q3 2023 in Review

NorthCrest Asset Manangement sold out of AtriCure (ATRC) in Q3 2023, closing a stake of 4,320 shares — an estimated $213K sold.

NorthCrest Asset Manangement first reported a position in ATRC in Q1 2022 and held it in 2 quarters. The position peaked at $213K in Q2 2023. 230 funds tracked by Wall St. Rank hold ATRC as of Q3 2023.

  • NorthCrest Asset Manangement reported no remaining AtriCure position as of Q3 2023 after selling out during the quarter.
  • NorthCrest Asset Manangement sold 4,320 AtriCure shares in Q3 2023, an estimated $213K.
  • NorthCrest Asset Manangement first reported a position in AtriCure in Q1 2022 and held it in 2 quarters.
  • NorthCrest Asset Manangement's AtriCure position peaked at $213K in Q2 2023.
  • 230 funds tracked by Wall St. Rank held AtriCure as of Q3 2023.

Based on NorthCrest Asset Manangement's 13F filing for Q3 2023, filed 13 Nov 2023.